US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist
  • 4.385
  • -0.445-9.21%
Trading Jan 10 14:48 ET
733.97MMarket Cap-1.68P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relay Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 50.000K --
-- 2024/Q4 -- / 6.080M --
Nov 6, 2024 2024/Q3 0.000 / 80.000K --
Aug 6, 2024 2024/Q2 0.000 / 88.890K --
May 2, 2024 2024/Q1 10.007M / 109.090K --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 50.000K--
--2024/Q4-- / 6.080M--
Nov 6, 20242024/Q30.000 / 80.000K--
Aug 6, 20242024/Q20.000 / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--

Unlock Free Earnings Estimates

Relay Therapeutics Earnings Reports

  • Relay Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 05:20

  • Relay Therapeutics | 8-K: Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

    Nov 7, 2024 05:13

  • Relay Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7, 2024 04:20

  • Relay Therapeutics | 8-K: Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

    Aug 7, 2024 04:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data